Literature DB >> 3262168

Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential.

W J Hrushesky1, S A Gruber, R B Sothern, R A Hoffman, D Lakatua, A Carlson, F Cerra, R L Simmons.   

Abstract

The timing within the estrous cycle of surgical removal of a transplanted murine mammary tumor profoundly influences the frequency of pulmonary metastases. We investigated the potential role of the immune response in this phenomenon by measuring splenic natural killer (NK) cell activity and interleukin-2 (IL-2) production in syngeneic tumor-free mice of two age groups at each of two circadian times and in each of four estrous stages. Estrous stage was determined by assessment of vaginal smear cellularity immediately prior to killing and spleen harvest. In a single-cell splenocyte preparation, NK cytotoxicity against a standard tumor cell target was assessed using a radiolabeled chromium release assay while IL-2 activity was determined in a bioassay utilizing the IL-2-dependent CTLL-2 cell line. Mice from the younger group were found to have eight-fold higher NK activity and 35% greater IL-2 production. After normalization of NK and IL-2 values for age, a highly statistically significant difference in NK activity was found among the four estrous and between the two circadian stages of sacrifice. NK activity was greater during the daily resting span across every estrous stage. IL-2 values were highest in diestrus and proestrus when sampled in the light span and in estrus-metestrus when sampled in the dark. The stages within the fertility cycle associated with lowest metastatic potential (proestrus/estrus) correspond precisely with those of highest splenocyte NK activity. These results indicate that an important component of the cellular immune response varies rhythmically both during the fertility and circadian cycles of the host. The rhythmic changes in NK activity may be in part responsible for the similarly rhythmic frequency of postsurgical metastatic dissemination.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262168     DOI: 10.1093/jnci/80.15.1232

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Menstrual history and breast cancer surgery.

Authors:  S A Gruber; K L Nichol; R B Sothern; M E Malone; J D Potter; D Lakatua; W J Hrushesky
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

2.  Estrous cycle modulates ovarian carcinoma growth.

Authors:  Guillermo N Armaiz-Pena; Lingegowda S Mangala; Whitney A Spannuth; Yvonne G Lin; Nicholas B Jennings; Alpa M Nick; Robert R Langley; Rosemarie Schmandt; Susan K Lutgendorf; Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

3.  Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients.

Authors:  W Jäger; W Sauerbrei
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

Review 4.  Sex hormone regulation of innate lymphoid cells.

Authors:  Eve Blanquart; Sophie Laffont; Jean-Charles Guéry
Journal:  Biomed J       Date:  2020-11-18       Impact factor: 4.910

5.  Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells.

Authors:  S Ben-Eliyahu; G G Page; G Shakhar; A N Taylor
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

6.  Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity.

Authors:  K Shakhar; G Shakhar; E Rosenne; S Ben-Eliyahu
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

7.  Progesterone and Src family inhibitor PP1 synergistically inhibit cell migration and invasion of human basal phenotype breast cancer cells.

Authors:  Mingxuan Xie; Li Zhou; Xi Chen; Lindsey O Gainey; Jian Xiao; Mark S Nanes; Anji Hou; Shaojin You; Qiong Chen
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

8.  Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update.

Authors:  Anushka Chaudhry; Michael L Puntis; Panos Gikas; Kefah Mokbel
Journal:  Int Semin Surg Oncol       Date:  2006-11-01

9.  Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.

Authors:  K Holli; J Isola; M Hakama
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

10.  An interferon signature identified by RNA-sequencing of mammary tissues varies across the estrous cycle and is predictive of metastasis-free survival.

Authors:  Antoine M Snijders; Sasha Langley; Jian-Hua Mao; Sandhya Bhatnagar; Kathleen A Bjornstad; Chris J Rosen; Alvin Lo; Yurong Huang; Eleanor A Blakely; Gary H Karpen; Mina J Bissell; Andrew J Wyrobek
Journal:  Oncotarget       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.